Polycaprolactone/gelatin Research Articles

Electrospun photothermal tellurium nanosheet-loaded polycaprolactone/gelatin nanofibers to promote wound healing

Low-cost and biodegradable photothermal wound dressings with remarkable therapeutic effects are highly desirable for next-generation wound healing. Herein, we report an efficient photothermal wound dressing mat made of tellurium nanosheet (TeNS)-loaded electrospun polycaprolactone/gelatin (PCL/GEL) nanofibers. The TeNS-loaded PCL/GEL nanofibrous architectures showed antibacterial efficacy against Escherichia coli and Staphylococcus aureus of 87.68% and 94.57%, respectively. Under near-infrared (NIR) light illumination, they can facilitate cell proliferation as revealed by in vitro scratch assay. The results from in vivo skin wounds combined with tissue staining experiments further showed that the TeNS-loaded dressing could substantially promote wound healing under photothermal conditions. Using immunohistochemical analysis, we found that the TeNS-loaded PCL/GEL nanofibers [Formula: see text] NIR group have a high expression of specific antigens in epidermal growth factor (EGF) ([Formula: see text]) and endothelial cell adhesion molecule-31 (CD31, [Formula: see text]), verifying that the nanofibrous mat can stimulate EGF generation and microvessel proliferation. Furthermore, the PCL/GEL/Te[Formula: see text]NIR group has the lowest expression in endothelial cell adhesion molecule-68 (CD68, [Formula: see text]), suggesting that the nanofibrous mats have a high anti-inflammatory efficiency. Our work sheds light on the development of novel nonanti-inflammatory wound dressings via photothermal sterilization and the promotion of cell growth using two-dimensional (2D) nanosheets.

A miniaturized multicellular platform to mimic the 3D structure of the alveolar-capillary barrier.

Several diseases affect the alveoli, and the efficacy of medical treatments and pharmaceutical therapies is hampered by the lack of pre-clinical models able to recreate in vitro the diseases. Microfluidic devices, mimicking the key structural and compositional features of the alveoli, offer several advantages to medium and high-throughput analysis of new candidate therapies. Here, we developed an alveolus-on-a-chip recapitulating the microanatomy of the physiological tissue by including the epithelium, the fibrous interstitial layer and the capillary endothelium. A PDMS device was obtained assembling a top layer and a bottom layer obtained by replica molding. A polycaprolactone/gelatin (PCL-Gel) electrospun membrane was included within the two layers supporting the seeding of 3cell phenotypes. Epithelial cells were grown on a fibroblast-laden collagen hydrogel located on the top side of the PCL-Gel mats while endothelial cells were seeded on the basolateral side of the membrane. The innovative design of the microfluidic device allows to replicate both cell-cell and cell-extracellular matrix interactions according to the in vivo cell arrangement along with the establishment of physiologically relevant air-liquid interface conditions. Indeed, high cell viability was confirmed for up to 10 days and the formation of a tight endothelial and epithelial barrier was assessed by immunofluorescence assays.

Anti-inflammatory and anti-oxidative electrospun nanofiber membrane promotes diabetic wound healing via macrophage modulation

BackgroundIn the inflammatory milieu of diabetic chronic wounds, macrophages undergo substantial metabolic reprogramming and play a pivotal role in orchestrating immune responses. Itaconic acid, primarily synthesized by inflammatory macrophages as a byproduct in the tricarboxylic acid cycle, has recently gained increasing attention as an immunomodulator. This study aims to assess the immunomodulatory capacity of an itaconic acid derivative, 4-Octyl itaconate (OI), which was covalently conjugated to electrospun nanofibers and investigated through in vitro studies and a full-thickness wound model of diabetic mice.ResultsOI was feasibly conjugated onto chitosan (CS), which was then grafted to electrospun polycaprolactone/gelatin (PG) nanofibers to obtain P/G-CS-OI membranes. The P/G-CS-OI membrane exhibited good mechanical strength, compliance, and biocompatibility. In addition, the sustained OI release endowed the nanofiber membrane with great antioxidative and anti-inflammatory activities as revealed in in vitro and in vivo studies. Specifically, the P/G-CS-OI membrane activated nuclear factor-erythroid-2-related factor 2 (NRF2) by alkylating Kelch-like ECH-associated protein 1 (KEAP1). This antioxidative response modulates macrophage polarization, leading to mitigated inflammatory responses, enhanced angiogenesis, and recovered re-epithelization, finally contributing to improved healing of mouse diabetic wounds.ConclusionsThe P/G-CS-OI nanofiber membrane shows good capacity in macrophage modulation and might be promising for diabetic chronic wound treatment.

Pro-vasculogenic Fibers by PDA-Mediated Surface Functionalization Using Cell-Free Fat Extract (CEFFE).

Formation of adequate vascular network within engineered three-dimensional (3D) tissue substitutes postimplantation remains a major challenge for the success of biomaterials-based tissue regeneration. To better mimic the in vivo angiogenic and vasculogenic processes, nowadays increasing attention is given to the strategy of functionalizing biomaterial scaffolds with multiple bioactive agents. Aimed at engineering electrospun biomimicking fibers with pro-vasculogenic capability, this study was proposed to functionalize electrospun fibers of polycaprolactone/gelatin (PCL/GT) by cell-free fat extract (CEFFE or FE), a newly emerging natural "cocktail" of cytokines and growth factors extracted from human adipose tissue. This was achieved by having the electrospun PCL/GT fiber surface coated with polydopamine (PDA) followed by PDA-mediated immobilization of FE to generate the pro-vasculogenic fibers of FE-PDA@PCL/GT. It was found that the PDA-coated fibrous mat of PCL/GT exhibited a high FE-loading efficiency (∼90%) and enabled the FE to be released in a highly sustained manner. The engineered FE-PDA@PCL/GT fibers possess improved cytocompatibility, as evidenced by the enhanced cellular proliferation, migration, and RNA and protein expressions (e.g., CD31, vWF, VE-cadherin) in the human umbilical vein endothelial cells (huvECs) used. Most importantly, the FE-PDA@PCL/GT fibrous scaffolds were found to enormously stimulate tube formation in vitro, microvascular development in the in ovo chick chorioallantoic membrane (CAM) assay, and vascularization of 3D construct in a rat subcutaneous embedding model. This study highlights the potential of currently engineered pro-vasculogenic fibers as a versatile platform for engineering vascularized biomaterial constructs for functional tissue regeneration.

Degradable and biocompatible nanofibrous scaffold incorporating a natural cell culture medium for skin tissue engineering

The use of green materials in biomedical and bioengineering applications has significantly expanded in recent years. In this study, we utilized egg white (EW) as an abundant and cost-effective green material, blended with polycaprolactone/gelatin (PCL/Gel), to fabricate an electrospun scaffold. The fabricated samples underwent comprehensive physicochemical characterization, including SEM, FT-IR spectroscopy, tensile assay, and contact angle measurement. These optimized samples were subsequently employed for cell culture experiments. The average diameter of the prepared nanofibers ranged from 215.9 to 434.1 nm. FT-IR and DSC assays confirmed the physical blending of EW, PCL, and Gel without any occurrence of new chemical reactions. The contact angle test demonstrated a decrease in scaffold hydrophilicity from 26.25° to 116.5° with an increase in EW content within the PCL/Gel blend (0%-15%). Notably, the electrospun PCL/Gel nanofibrous mat containing 10% EW exhibited enhanced bioactivity compared to other samples with varying amounts of EW. Consequently, incorporating 10% EW into PCL/Gel nanofibers can significantly improve the efficiency of fibroblast culture. This research introduces a novel nanofibrous scaffold for skin tissue engineering, incorporating Gel and EW as low-cost and readily available materials, with great potential for various biological applications.

Modified Highly Elastic 3D Nanofiber Embolic Scaffolds for Precise In Situ Embolization Therapy

AbstractTranscatheter arterial embolization (TAE) is an effective treatment for hemangiomas or highly vascular tumors. However, conventional embolic agents have limitations such as off‐target embolization, regurgitation, and embolic migration, which can affect the efficacy and safety of embolic therapy. The study designed a highly elastic modified embolic scaffold constructed with Polycaprolactone/Gelatin (PCL/GEL) nanofibers to achieve precise in situ embolization in vivo. The embolic scaffolds can be extruded to a small size for smooth intervention in the vessel and rapidly regain their volume when reaching the target area. The results of the in vitro study indicate that the embolic scaffolds modified with lysine and PEI exhibit good biocompatibility and functionality. Furthermore, the in vivo rabbit ear embolization test demonstrated that the modified embolic scaffolds fit closely to the vessels and induced a significant amount of neo tissue deposition in the embolized area. The embolization process using the modified embolic scaffolds is safe and stable and results in more desirable embolization outcomes compared to commercial gelatin embolic agents. In conclusion, the modified highly elastic embolic scaffolds designed in this study offer a novel method for in situ embolization that has potential for clinical application in TAE.

Nanofiber/hydrogel composite scaffolds based on alginate sulfate and extracellular matrix for cartilage tissue engineering applications

In this study, a three-layer composite scaffold was fabricated based on co-electrospun polycaprolactone/gelatin (PCL/GT) and polyvinyl alcohol/gelatin sacrificial nanofiber, alginate/alginate sulfate hydrogel and decellularized extracellular matrix powder. The novelty of this study is the fabrication of co-electrospun PCL/GT and polyvinyl alcohol nanofibers, which are modified by the sacrificial agent method, alginate/alginate-sulfate hydrogels, and DECM powder as growth factors with the aim of cell infiltration. Comparing the results of the microscopy images of the co-electrospun nanofibers before and after the washing process revealed that the distance between nanofibers increased from 2 ± 0.3–8 ± 0.1 µm. Furthermore, an increase in the porosity of prepared nanofibers by the washing process was observed. In addition, cell morphology studies showed that after 7 days, the cells could penetrate the underlay of nanofibers. Decellularized extracellular matrix powder in a hydrogel medium improved cell adhesion. The scaffold's porosity was tested to evaluate the ability of the cells to penetrate. The results showed that the percentage of porosity in optimized nanofiber is 94.4 ± 1.4%, which increased by 14% compared to PCL/GT with the conventional electrospinning method. Moreover, by preparing the optimal multi-layer composite, the porosity percentage was about 93.3 ± 1%. Finally, to investigate cell infiltration, cell seeding was performed on the optimal multi-layer composite for 7 and 14 days. H&E and DAPI staining analysis demonstrated that the cell penetration process through the optimal nanofiber layer was successful.

Development of Ag NPs/allantoin loaded PCL/GEL electrospun nanofibers for topical wound treatment.

In the present study, the allantoin and silver nanoparticle (Ag NPs) loaded poly caprolactone/gelatin (PCL/GEL) nanofibers produced using electrospinning technique and their cyto-compatibility and wound healing activity were evaluated in vitro and in vivo. The SEM imaging revealed diameters of 278.8 ± 10 and 240.6 ± 12nm for PCL/GEL/Ag NPs and PCL/GEL/Ag NPs/allantoin scaffolds. The Ag NPs entrapment into scaffolds was evaluated by FTIR analysis and EDX mapping. Both scaffolds containing Ag NPs and Ag NPs/allantoin exhibited valuable wound healing activity in Wistar rat animal model. The profound granulation tissue formation, high collagen deposition in coordination with low level of edema and inflammatory cells in Ag NPs/allantoin loaded scaffolds resulted in complete and mature re-epithelialization in giving the healing score (12 out of 12) equal to positive control group to the wounds treated with these scaffolds. It was concluded that the Ag NPs/allantoin loaded scaffolds regarding to their good antibacterial activity and excellent wound healing activity could be introduced as new effective wound dressing materials.

Development of biomimetic co-culture and tri-culture models to mimic the complex structure of the alveolar-capillary barrier

Alveoli are the functional area of respiratory system where the gaseous exchanges take place at level of the alveolar-capillary barrier. The development of safe and effective therapeutic approaches for treating lung disease is currently limited due to the lack of realistic preclinical models for their testing and validation. In this work, tissue engineering approaches were exploited to develop a biomimetic platform that provide an appropriate mimicking of the extracellular environment and the multicellular architecture of human alveoli. Here, we propose the implementation of two biomimetic in vitro models to reproduce the features of the main anatomic portions of the physiological alveolar-capillary barrier. First, a co-culture barrier model was obtained by integrating an electrospun polycaprolactone-gelatin (PCL-Gel) membrane in a modified transwell insert (PCL-Gel TW) to mimic the alveolar basement membrane (coded as thin model). Alveolar epithelial (A549) and lung microvascular endothelial (HULEC-5a) cells were cultured on the apical and basolateral side of the PCL-Gel membrane, respectively, under physiologic air-liquid interface (ALI) conditions for 7 days. The ALI condition promoted the expression of type I and type II alveolar epithelial cell markers and the secretion of mucus in A549 cells. Increased cell viability and barrier properties in co-cultures of A549 and HULEC-5a compared to mono-cultures revealed the effectiveness of the model to reproduce in vitro physiological-relevant features of the alveolar-capillary barrier.The second portion of the alveolar-capillary barrier was developed implementing a tri-culture model (coded as thick model) including a type I collagen (COLL) hydrogel formulated to host lung fibroblasts (MRC-5). The thick barrier model was implemented by seeding HULEC-5a on the basolateral side of PCL-Gel TW and then pouring sequentially MRC-5-laden COLL hydrogel and A549 cells on the apical side of the electrospun membrane. The thick model was maintained up to 7 days at ALI and immunofluorescence staining of tight and adherent junctions demonstrated the formation of a tight barrier.Lastly, the ability of models to emulate pathological inflammatory conditions was validated by exposing the apical compartment of the PCL-Gel TW to lipopolysaccharide (LPS). The damage of A549 tight junctions, the increase of barrier permeability and IL-6 pro-inflammatory cytokine release was observed after 48 h exposure to LPS.

Preparation of co-electrospinning membrane loaded with simvastatin and substance P to accelerate bone regeneration by promoting cell homing, angiogenesis and osteogenesis.

Bone regeneration is a complex process that requires the coordination of various biological events. Developing a tissue regeneration membrane that can regulate this cascade of events is challenging. In this study, we aimed to fabricate a membrane that can enrich the damaged area with mesenchymal stem cells, improve angiogenesis, and continuously induce osteogenesis. Our approach involved creating a hierarchical polycaprolactone/gelatin (PCL/GEL) co-electrospinning membrane that incorporated substance P (SP)-loaded GEL fibers and simvastatin (SIM)-loaded PCL fibers. The membrane could initiate a burst release of SP and a slow/sustained release of SIM for over a month. In vitro experiments, including those related to angiogenesis and osteogenesis (e.g., migration, endothelial network formation, alkaline phosphatase activity, mineralization, and gene expression), clearly demonstrated the membrane's superior ability to improve cell homing, revascularization, and osteogenic differentiation. Furthermore, a series of in vivo studies, including immunofluorescence of CD29+/CD90+ double-positive cells and immunohistochemical staining for CD34 and vWF, confirmed the co-electrospinning membrane's ability to enhance MSC migration and revascularization response after five days of implantation. After one month, the Micro-CT and histological (Masson and H&E) results showed accelerated bone regeneration. Our findings suggest that a co-electrospinning membrane with time-tunable drug delivery could advance the development of tissue engineering therapeutic strategies and potentially improve patient outcomes.

Ultrathin, flexible, and piezoelectric Janus nanofibrous dressing for wound healing

The healing process of infected skin lesions is often delayed by many factors including bacterial infection, excessive accumulation of wound exudate, poor local perfusion, and low cell recruitment. Development of wound dressing for efficient wound management and promotion of wound healing is a great challenge. Herein, we constructed a Janus nanofiber dressing with the comprehensive capacities of bacterial killing, piezoelectrical stimulation for promoting fibroblast migration, and wound exudate removal via unidirectional liquid delivery. The rationally designed Janus nanofibrous dressing with ultrathin, flexible, breathable, and piezoelectric characteristics is fabricated via the facile layer-by-layer electrostatic spinning technology. The hydrophilic layer of the dressing is composed of randomly arranged polycaprolactone/gelatin (PCL/Gel) nanofibers, while the hydrophobic layer consists of well-aligned Ag nanoparticles (Ag NPs)-doped piezoelectric polyvinylidene fluoride (PVDF/Ag) nanofibers. The in vitro and in vivo experimental results demonstrate that the Janus dressing can not only drain excess wound exudate out of the wound unidirectionally and kill local bacteria, but also generate dynamic piezopotential under normal body motions to promote fibroblast proliferation and migration, collagen deposition, angiogenesis, and re-epithelialization, which accelerates rapid wound healing on mice. The smart Janus dressing will provide a new approach for acceleration of wound healing and wound management.

Cell-based wound dressing: Bilayered PCL/gelatin nanofibers-alginate/collagen hydrogel scaffold loaded with mesenchymal stem cells

Wound dressing is applied to promote the healing process, wound protection, and additionally regeneration of injured skin. In this study, a bilayer scaffold composed of a hydrogel and nanofibers was fabricated to improve the regeneration of injured skin. To this end, polycaprolactone/gelatin (PCL/Gel) nanofibers were electrospun directly on the prepared collagen/alginate (Col/Alg) hydrogel. The bilayer scaffold was characterized by scanning electron microscopy (SEM), Fourier transform infrared (FTIR), mechanical properties, and swelling/degradation time. Cytotoxicity assays were evaluated using MTT assay. Then, the nanofiber and bilayer scaffolds were seeded with Adipose-derived stem cells (ADSCs). ADSCs were isolated from rat adipose tissue and analyzed using flow cytometry, in advance. Full-thickness wounds on the backs of rats were dressed with ADSCs-seeded bilayer scaffolds and nanofibers. Histopathological evaluations were performed after 14 and 21 days using H&E (hematoxylin and eosin) staining. The results indicated that re-epithelialization, angiogenesis, and collagen remodeling were enhanced in ADSCs-seeded bilayer scaffolds and nanofibers in comparison with the control group. In conclusion, the best re-epithelialization, collagen organization, neovascularization, and low presence of inflammation in the wound area were observed in the ADSCs-seeded bilayer scaffolds.

ZnO nanoparticles-modified polycaprolactone-gelatin membranes for guided/bone tissue regeneration, antibacterial and osteogenic differentiation properties

Periodontitis is a highly prevalent infectious disease that causes the progressive destruction of the periodontal supporting tissues. If left untreated, it can lead to tooth loss impairing oral function, aesthetics, and the patient’s overall quality of life. Guided and Bone Tissue Regeneration (GTR/BTR) are surgical therapies based on the placement of a membrane that prevents epithelial growth into the defect, allowing the periodontal/bone cells (including stem cells) to regenerate or restore the affected tissues. The success of these therapies is commonly affected by the local bacterial colonization of the membrane area and its fast biodegradation, causing postoperative infections and a premature rupture of the membrane limiting the regeneration process. This study presents the antibacterial and osteogenic differentiation properties of polycaprolactone-gelatin (PCL-G) electrospun membranes modified with ZnO nanoparticles (ZnO-NPs). The membranes´ chemical composition, surface roughness, biodegradation, water wettability, and mechanical properties under simulated physiological conditions, were analyzed by the close relationship with their biological properties. The PCL-G membranes modified with 1, 3, and 6% w/w of ZnO-NPs showed a significant reduction in the planktonic and biofilm formation of four clinically relevant bacteria; A. actinomycetemcomitans serotype b, P. gingivalis, E. coli, and S. epidermidis. Additionally, the membranes presented appropriate mechanical properties and biodegradation rates to be potentially used in clinical treatments. Notably, the membranes modified with the lowest concentration of ZnO-NPs (1% w/w) stimulated the production of osteoblast markers and calcium deposits in human bone marrow-derived mesenchymal stem cells (BM-MSC) and were biocompatible to human osteoblasts cells (hFOB). These results suggest that the PCL-G membranes with 1% w/w of ZnO-NPs are high-potential candidates for GTR/BTR treatments, as they were the most effective in terms of better antibacterial effectiveness at a lower NPs-concentration while creating a favorable cellular microenvironment for bone growth.

3D Polycaprolactone/Gelatin-Oriented Electrospun Scaffolds Promote Periodontal Regeneration.

Periodontitis is a worldwide chronic inflammatory disease, where surgical treatment still shows an uncertain prognosis. To break through the dilemma of periodontal treatment, we fabricated a three-dimensional (3D) multilayered scaffold by stacking and fixing electrospun polycaprolactone/gelatin (PCL/Gel) fibrous membranes. The biomaterial displayed good hydrophilic and mechanical properties. Besides, we found human periodontal ligament stem cell (hPDLSC) adhesion and proliferation on it. The following scanning electron microscopy (SEM) and cytoskeleton staining results proved the guiding function of fibers to hPDLSCs. Then, we further analyzed periodontal regeneration-related proteins and mRNA expression between groups. In vivo results in a rat acute periodontal defect model confirmed that the topographic cues of materials could directly guide cellular orientation and might provide the prerequisite for further differentiation. In the aligned scaffold group, besides new bone regeneration, we also observed that angular concentrated fiber regeneration in the root surface of the defect is similar to the normal periodontal tissue. To sum up, we have constructed electrospun membrane-based 3D biological scaffolds, which provided a new treatment strategy for patients undergoing periodontal surgery.

Research on Polycaprolactone-Gelatin Composite Scaffolds Carrying Nerve Growth Factor for the Repair of Spinal Cord Injury.

Objective This study was to investigate the mechanism of action of polycaprolactone/gelatin (PCL/GE) composite fiber scaffold with nerve growth factor (NGF) in the recovery of spinal cord injury (SCI). Methods Sixty female Sprague-Dawley (SD) rats were randomly assigned to the negative control group, the positive control group, the PCL/GE scaffold group, and the collagen-binding structural domain nerve growth factor (CBD-NGF)/PCL/GE scaffold group, with 15 rats in each group. Spinal cord transection was used to establish SCI models in rats. The negative control group received sham surgery, while the other three groups were given spinal cord transection at the tenth thoracic vertebra (T10) segment. The rats in the PCL/GE scaffold group were implanted with a 4 mm PCL/GE composite fiber scaffold, and those in the CBD-NGF/PCL/GE scaffold group were implanted with a CBD-NGF/PCL/GE composite fiber scaffold. The Basso–Beattie–Bresnahan (BBB) locomotor rating scale was used to evaluate the locomotor ability of the hind limbs of the rats, and the amplitude and latency of motor evoked potentials (MEP) were recorded by neurophysiological testing at 12 w postoperatively. The levels of growth-associated protein 43 (GAP43) and neurofilament protein 200 (NF200) in the spinal cord tissue of the injury site were determined using Western Blot at 12 w after surgery. Spinal cord tissues of 2 cm within the injury site, the thoracic segment above the injury site, and the lumbar segment below the injury site were collected from the measurement of axonal transport using fluorescent retrograde tracer fluorogold, and the integrated absorbance (IA) values of FC-positive cells were calculated. Results After treatment, the negative control rats showed normal locomotion function of the hind limb with the highest BBB scores, while the positive control rats had the lowest BBB scores and showed paraplegia. The scaffold groups exhibited better locomotion function of the hind limb and higher BBB scores than the positive controls, with greater improvement observed in the CBD-NGF/PCL/GE scaffold group (P < 0.05). Compared with the positive controls, the PCL/GE scaffold group and CBD-NGF/PCL/GE scaffold group exhibited significantly shorter latency and increased amplitude of MEP, with more significant changes observed in the CBD-NGF/PCL/GE scaffold group (P < 0.05). Compared with the positive control group, the GAP43 and NF200 levels of spinal cord tissue were significantly elevated in both the PCL/GE scaffold group and the CBD-NGF/PCL/GE scaffold group, and the changes were more pronounced in the CBD-NGF/PCL/GE scaffold group (P < 0.05). The differences in the IA values of FC-positive cells in the spinal cord tissue of the lumbar segment below the injury site among the four groups did not come up to the statistical standard (P > 0.05). Compared with the positive control group, the FC-positive cell IA values of spinal cord tissue in the thoracic segment above the injury area were markedly increased in the PCL/GE scaffold group and the CBD-NGF/PCL/GE scaffold group, and the alterations were more significant in the CBD-NGF/PCL/GE scaffold group (P < 0.05). Conclusion PCL/GE composite fiber scaffold with NGF significantly improves motor and neurological functions in the hind limbs of SCI rats and promotes the recovery of axonal transport, and the mechanism may be associated with the upregulation of GAP43 and NF200 levels in spinal cord injury site tissues.

Fabrication and characterization of electrospun nanofibrous mats of polycaprolactone/gelatin containing ZnO nanoparticles and cumin essential oil and their anti-staphylococcal potency in white cheese

Different concentrations of cumin essential oil (CEO) and zinc oxide nanoparticles (ZnO NPs) were incorporated in polycaprolactone-gelatin (PCL/Gel) to fabricate five nanofiber mats for anti-Staphylococcus aureus activity purposes in cheese. GC-MS analysis of the CEO revealed nineteen constituents. The cuminaldehyde was the most abundant (35.21%) component. FESEM analyses showed the fiber diameters in a range between 179 ± 88 and 277 ± 165 nm. The band intensities of ATR-FTIR spectra confirmed the proper incorporation and encapsulation of ZnO NPs and/or CEO in the PCL/Gel blend. EDS analyses indicated the characteristic peaks of the nanoparticles, and elemental mapping proved the proper distribution of ZnO NPs in nanofibers. Based on TGA and DTG results, increasing ZnO NPs and/or CEO to 3% improved the thermal stability of mats. Water contact angles (WCAs) of the mats increased by adding ZnO NPs and/or CEO concentrations after 0, 1, 3, and 5 s. Incorporating CEO/ZnO NPs, particularly at the concentration of 3%, led to significant improvement of tensile strength, elongation at break, and Young's modulus of the mat. According to the MTT cell viability assay, the mats had no detrimental influence on Human Dermal Fibroblasts. The CEO/ZnO NPs-loaded mats could markedly decrease or slow the bacterial growth during 12 days of cold storage of cheese samples. The sensory attributes of cheese samples treated with the CEO/ZnO NPs-loaded mat were improved during the storage period. This investigation suggested that the PCL/Gel/CEO/ZnO electrospun fibrous mats were efficient in gaining anti-staphylococcal properties and were promising for food packaging.

Control of drug release from cotton fabric by nanofibrous mat

A drug delivery system (DDSs) was developed in the present study based on textile substrates as drug carriers and electrospun nanofibers as a controller of release rate. Three types of drugs consisting of ciprofloxacin (CIP), clotrimazole (CLO), and benzalkonium chloride (BEN) were loaded into the cover glass (CG) and cotton fabrics (CF1 and CF2) separately. Then, the drug-loaded substrates were coated with polycaprolactone (PCL) and polycaprolactone/gelatin (PCL/Gel) nanofibers with various thicknesses. The morphology and hydrophilicity of the electrospun nanofibers and the release profile of drug-loaded samples were investigated. FTIR, XRD, and in vitro biodegradability analysis were analyzed to characterize the drug delivery system. A morphological study of electrospun fibers showed the mean diameter of the PCL and PCL/Gel nanofibers 127 ± 25 and 178 ± 38 nm, respectively. The drug delivery assay revealed that various factors affect the rate of drug releases, such as the type of drug, the type of drug carrier, and the thickness of the covered nanofibers. The study highlights the ability of drugs to load substrates with coated nanofibers as controlled drug delivery systems. In conclusion, it is shown that the obtained samples are excellent candidates for future wound dressing applications.

Photothermal-responsive fiber dressing with enhanced antibacterial activity and cell manipulation towards promoting wound‐healing

For chronic persistent skin injuries, functional wound dressings with improved antibacterial action and cell control are extremely appealing. In this study, we design and fabricate a composite fiber dressing with near-infrared (NIR) laser-induced hyperthermia and transformable topographies that can protect the wound from bacterial infection while also encouraging cell recruitment and tissue regeneration. Polycaprolactone/gelatin (PCL/Gel) with melting point close to photothermal temperature were electrospun as the supporting matrix. The zeolitic imidazolate framework-8 (ZIF-8)-derived nanocarbon was synthesized as NIR laser-triggered nanoagent and then electrospun within oriented PCL/Gel fibers to enable the inorganic/polymer composite fiber dressing with photo-to-thermal conversion effect and drug loading capability. The composite fiber dressing exhibits excellent photothermal performance and stage-specific transformable topographies (photothermal-triggered melting behavior of oriented PCL/Gel fibers) after multiple laser irradiations, which can generate local massive heat and abundant drug release for synergistic sterilization, as well as direct cell migration and adhesion/spreading to promote tissue regeneration. Furthermore, in vivo testing demonstrates that the photothermal-responsive fiber dressing accelerates wound closure process by synergistically improving antibacterial and cell manipulation. Overall, this composite fiber dressing offers a promising integrated wound healing strategy.

Anticancer efficacy of lupeol incorporated electrospun Polycaprolactone/gelatin nanocomposite nanofibrous mats

Despite the anticancer effect of lupeol (Lup), low aqueous solubility can make its therapeutic usage difficult. However, polycaprolactone/Gelatin (PCL-GEL) nanofibers scaffold eliminates this problem. This study has been conducted to recognize PCL-GEL-Lup nanofibers effect on cancer cell lines. PCL-GEL solution was prepared at different ratios (8 wt% and 4 wt%) for achieving optimal nanofibers. PCL-GEL-Lup nanofibers were provided via electrospinning technique. The surface morphology of nanofibers was examined using FESEM. Functional groups were investigated by a Fourier Transform Infrared spectroscopy. Lupeol released from nanofibers was detected by a UV–Visible spectroscopy. The drug release profile confirmed the sustained release of about 80% achieved within 40 h. IC50 of lupeol against ACHN and HSC-3 cell lines are 52.57 and 66.10 μg ml−1 respectively. The study results from aid an understanding of the fabrication of a scaffold with an optimum dose of bioactive lupeol in 6 wt% with bead free uniform diameter that is capable of binding the drug efficiently. The enhanced cytotoxicity activity by effective diffusion and elution to the target achieved in this study help to develop a nanofiber in the ongoing battle against cancer.

Bone morphogenetic protein (BMP)-modified graphene oxide-reinforced polycaprolactone–gelatin nanofiber scaffolds for application in bone tissue engineering

In this study, blend nanofibrous scaffolds were electrospun from polycaprolactone/gelatin (PCL/Gel) blend solutions reinforced by bone morphogenetic protein (BMP)-modified graphene oxide (GO). SEM results showed that uniform and bead-less nanofibers with 270nm average diameter were obtained from electrospun of PCL/Gel blend solutions. Tensile strength test and contact angle measurement demonstrated that addition of PCL led to higher mechanical and physical properties of the resulting nanofibers. The addition of PCL as well as GO in the blend supports the suitable mechanical strength in the body media. The loading of BMP-modified graphene in the Gel/PCL structure caused the formation of nanofibrous substrate with great resemblance to bone tissue. Gel/PCL-G hybrid nanofibers revealed good biocompatibility in the presence of human osteosarcoma cells, and no trace of cellular toxicity was observed. The cells grown on the scaffolds exhibited a spindle-like and broad morphology and almost uniformly covered the entire nanofiber scaffold. Gel/PCL nanofibers reinforced by graphene oxide-immobilized bone morphogenetic protein was prepared as a promising safe and biocompatible nanofiber with high antibacterial activity for bone tissue engineering.